John Renger, Chief Scientific Officer at Cerevel Therapeutics Holdings, Inc. (CERE), sold 45,000 shares at $30.00 ($1.4M) on 2022-03-16, disclosed to the SEC on 2022-03-18.
Open-market sale of $1.4M CERE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 25,000 | $750K | 53.6% |
| 2 | $32.50 | 20,000 | $650K | 46.4% |
| Total | $31.11 avg | 45,000 | $1.4M | 100% |
| Filing → |
| CERE | SELL | 2022-10-06 | $750K | — | Filing → |
| CERE | SELL | 2022-08-12 | $4.5M | — | Filing → |
| CERE | SELL | 2022-08-09 | $1.0M | — | Filing → |